Quarterly UpdatesJul 1, 2026, 08:32 AM
Milestone Scientific Q2 Revenue $2.8M, Medical Segment +300%
AI Summary
Milestone Scientific Inc. announced preliminary, unaudited revenue for Q2 2026, expecting approximately $2.8 million, a 21% increase year-over-year. The medical segment showed significant momentum with an anticipated 300% revenue growth compared to Q2 2025. The company also reported progress in reimbursement efforts and international expansion for its dental business, alongside plans to showcase its technology at an upcoming conference.
Key Highlights
- Preliminary Q2 2026 total revenue expected at approximately $2.8 million, up 21% year-over-year.
- Preliminary H1 2026 total revenue expected at approximately $5.0 million, up 9% year-over-year.
- Medical segment revenue expected to grow 300% in Q2 2026 compared to Q2 2025.
- Base business contributed approximately $2.4 million in Q2 revenue.
- International orders added approximately $500,000 in Q2 revenue.
- Successfully submitted 100 medical claims for reimbursement and secured first paid workers' compensation claim.
- Secured dental approval in Uzbekistan, with plans for Japan, Mexico, Turkey, and India.
- Company to showcase technology at the American Society of Pain & Neuroscience (ASPN) Conference.
Price Impact
More from MLSS